Begin main content

Reports

We found 4614 result(s)

OnabotulinumtoxinA (Botox)

Published on: January 31, 2012
Result type: Reports
Product Line: Common Drug Review
Generic Name: OnabotulinumtoxinA
Indications: Neurogenic Detrusor Overactivity

  • Brand Name: Botox
  • Manufacturer: Allergan Inc.
  • Project Number: SR0268
  • Project Status: Complete
  • Submission Type: New

Rituximab (Rituxan)

Published on: February 24, 2012
Result type: Reports
Product Line: Common Drug Review
Generic Name: Rituximab
Indications: Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA), remission induction (adults)

  • Brand Name: Rituxan
  • Manufacturer: Hoffman-La Roche Ltd.
  • Project Number: SR0270
  • Project Status: Complete
  • Submission Type: NewIndication

Fesoterodine fumarate (Toviaz)

Published on: April 27, 2012
Result type: Reports
Product Line: Common Drug Review
Generic Name: Fesoterodine fumarate
Indications: Bladder, overactive

  • Brand Name: Toviaz
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: SR0277
  • Project Status: Complete
  • Submission Type: New

Mometasone/formoterol (Zenhale)

Published on: June 6, 2012
Result type: Reports
Product Line: Common Drug Review
Generic Name: Mometasone/formoterol
Indications: Asthma maintenance (adults, children 12 or older)

  • Brand Name: Zenhale
  • Manufacturer: Merck Canada Inc.
  • Project Number: S0281
  • Project Status: Complete
  • Submission Type: RequestForAdvice

Collagenase clostridium histolyticum (Xiaflex)

Published on: August 30, 2012
Result type: Reports
Product Line: Common Drug Review
Generic Name: Collagenase clostridium histolyticum
Indications: Dupuytren’s contracture with a palpable cord

  • Brand Name: Xiaflex
  • Manufacturer: Auxilium Pharmaceuticals, Inc. & Actelion Pharmaceuticals Canada Inc.
  • Project Number: SR0287
  • Project Status: Complete
  • Submission Type: New

Eculizumab (Soliris)

Published on: January 7, 2013
Result type: Reports
Product Line: Common Drug Review
Generic Name: Eculizumab
Indications: Hemolytic Uremic Syndrome, Atypical

  • Brand Name: Soliris
  • Manufacturer: Alexion Pharma Canada
  • Project Number: SR0304
  • Project Status: Complete
  • Submission Type: Pre-NOC

Telaprevir (Incivek)

Published on: January 2, 2013
Result type: Reports
Product Line: Common Drug Review
Generic Name: Telaprevir
Indications: Hepatitis C, chronic

  • Brand Name: Incivek
  • Manufacturer: Vertex Pharmaceuticals Canada Inc.
  • Project Number: SF0305-000
  • Project Status: Complete
  • Submission Type: RequestForAdvice

Tags

Hepatitis C, Chronic, Hepatitis

Everolimus (Afinitor)

Published on: March 8, 2013
Result type: Reports
Product Line: Common Drug Review
Generic Name: Everolimus
Indications: renal angiomyolipoma associated with tuberous sclerosis complex (TSC)

  • Brand Name: Afinitor
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0315-000
  • Project Status: Complete
  • Submission Type: New

Tags

Angiomyolipoma, Tuberous Sclerosis